ProfileGDS4516 / 205625_s_at
TitleColorectal cancer: laser microdissected tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 1 stage: 2a stage: 2b stage: 3a stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM537341 GSM537345 GSM537355 GSM537366 GSM537370 GSM537380 GSM537392 GSM537415 GSM537417 GSM537422 GSM537423 GSM537427 GSM537430 GSM537336 GSM537337 GSM537348 GSM537349 GSM537356 GSM537361 GSM537374 GSM537377 GSM537378 GSM537379 GSM537383 GSM537388 GSM537395 GSM537400 GSM537404 GSM537409 GSM537418 GSM537425 GSM537333 GSM537342 GSM537347 GSM537350 GSM537362 GSM537363 GSM537368 GSM537376 GSM537381 GSM537386 GSM537398 GSM537402 GSM537405 GSM537371 GSM537421 GSM537424 GSM537432 GSM537331 GSM537332 GSM537334 GSM537338 GSM537353 GSM537357 GSM537358 GSM537375 GSM537389 GSM537390 GSM537393 GSM537399 GSM537407 GSM537408 GSM537428 GSM537354 GSM537410 GSM537413 GSM537396 GSM537397 GSM537330 GSM537369 GSM537373 GSM537401 GSM537343 GSM537367 GSM537382 GSM537385 GSM537391 GSM537419 GSM537420 GSM537429 GSM537431 GSM537387 GSM537414 GSM537433 GSM537335 GSM537339 GSM537340 GSM537344 GSM537346 GSM537351 GSM537352 GSM537359 GSM537360 GSM537364 GSM537365 GSM537372 GSM537384 GSM537394 GSM537403 GSM537406 GSM537411 GSM537412 GSM537416 GSM537426 16% 16% 14% 9% 9% 2% 6% 7% 31% 21% 10% 9% 9% 10% 12% 19% 12% 6% 26% 6% 99% 11% 47% 15% 7% 4% 79% 5% 10% 99% 10% 88% 10% 12% 9% 10% 12% 17% 8% 87% 17% 8% 9% 24% 20% 8% 16% 10% 14% 24% 83% 8% 8% 39% 8% 21% 10% 14% 7% 11% 10% 6% 7% 19% 8% 27% 10% 7% 41% 7% 8% 18% 28% 8% 11% 12% 8% 9% 23% 24% 29% 89% 12% 24% 12% 14% 13% 17% 23% 9% 11% 8% 10% 18% 6% 7% 15% 27% 18% 34% 11% 14% 10% 12% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM537341patient 115, cancer, LCM [OPG study]3.7455316
GSM537345patient 119, cancer, LCM [OPG study]3.720316
GSM537355patient 138, cancer, LCM [OPG study]3.6779314
GSM537366patient 154, cancer, LCM [OPG study]3.449849
GSM537370patient 022, cancer, LCM [OPG study]3.420749
GSM537380patient 037, cancer, LCM [OPG study]3.114742
GSM537392patient 077, cancer, LCM [OPG study]3.316186
GSM537415patient 032, cancer, LCM [OPG study]3.326297
GSM537417patient 042, cancer, LCM [OPG study]4.4812131
GSM537422patient 059, cancer, LCM [OPG study]3.9673121
GSM537423patient 064, cancer, LCM [OPG study]3.4594210
GSM537427patient 084, cancer, LCM [OPG study]3.400289
GSM537430patient 090, cancer, LCM [OPG study]3.450869
GSM537336patient 107, cancer, LCM [OPG study]3.4807210
GSM537337patient 108, cancer, LCM [OPG study]3.5198512
GSM537348patient 124, cancer, LCM [OPG study]3.8487619
GSM537349patient 125, cancer, LCM [OPG study]3.5512712
GSM537356patient 139, cancer, LCM [OPG study]3.311416
GSM537361patient 147, cancer, LCM [OPG study]4.1879426
GSM537374patient 026, cancer, LCM [OPG study]3.353766
GSM537377patient 033, cancer, LCM [OPG study]12.89999
GSM537378patient 034, cancer, LCM [OPG study]3.525311
GSM537379patient 036, cancer, LCM [OPG study]5.2356647
GSM537383patient 046, cancer, LCM [OPG study]3.7092715
GSM537388patient 063, cancer, LCM [OPG study]3.33947
GSM537395patient 082, cancer, LCM [OPG study]3.175514
GSM537400patient 099, cancer, LCM [OPG study]7.7804979
GSM537404patient 129, cancer, LCM [OPG study]3.334095
GSM537409patient 141, cancer, LCM [OPG study]3.4683310
GSM537418patient 044, cancer, LCM [OPG study]12.788399
GSM537425patient 070, cancer, LCM [OPG study]3.5124510
GSM537333patient 102, cancer, LCM [OPG study]8.9566588
GSM537342patient 116, cancer, LCM [OPG study]3.494310
GSM537347patient 123, cancer, LCM [OPG study]3.6268912
GSM537350patient 127, cancer, LCM [OPG study]3.474389
GSM537362patient 148, cancer, LCM [OPG study]3.5199210
GSM537363patient 150, cancer, LCM [OPG study]3.5690912
GSM537368patient 156, cancer, LCM [OPG study]3.7698817
GSM537376patient 031, cancer, LCM [OPG study]3.445418
GSM537381patient 038, cancer, LCM [OPG study]8.8491287
GSM537386patient 057, cancer, LCM [OPG study]3.7938717
GSM537398patient 094, cancer, LCM [OPG study]3.397428
GSM537402patient 109, cancer, LCM [OPG study]3.460689
GSM537405patient 130, cancer, LCM [OPG study]4.1409424
GSM537371patient 023, cancer, LCM [OPG study]3.9262220
GSM537421patient 055, cancer, LCM [OPG study]3.389158
GSM537424patient 065, cancer, LCM [OPG study]3.7624416
GSM537432patient 097, cancer, LCM [OPG study]3.5022710
GSM537331patient 100, cancer, LCM [OPG study]3.6489614
GSM537332patient 101, cancer, LCM [OPG study]4.0469924
GSM537334patient 103, cancer, LCM [OPG study]8.2037783
GSM537338patient 110, cancer, LCM [OPG study]3.408628
GSM537353patient 135, cancer, LCM [OPG study]3.401988
GSM537357patient 142, cancer, LCM [OPG study]4.7576339
GSM537358patient 143, cancer, LCM [OPG study]3.391758
GSM537375patient 030, cancer, LCM [OPG study]3.9473221
GSM537389patient 068, cancer, LCM [OPG study]3.4116510
GSM537390patient 072, cancer, LCM [OPG study]3.6163914
GSM537393patient 078, cancer, LCM [OPG study]3.317357
GSM537399patient 095, cancer, LCM [OPG study]3.5496311
GSM537407patient 133, cancer, LCM [OPG study]3.5280210
GSM537408patient 140, cancer, LCM [OPG study]3.322066
GSM537428patient 086, cancer, LCM [OPG study]3.391767
GSM537354patient 136, cancer, LCM [OPG study]3.8348519
GSM537410patient 146, cancer, LCM [OPG study]3.420098
GSM537413patient 027, cancer, LCM [OPG study]4.1443427
GSM537396patient 083, cancer, LCM [OPG study]3.4944810
GSM537397patient 088, cancer, LCM [OPG study]3.35847
GSM537330patient 006, cancer, LCM [OPG study]4.908841
GSM537369patient 015, cancer, LCM [OPG study]3.372827
GSM537373patient 025, cancer, LCM [OPG study]3.38238
GSM537401patient 106, cancer, LCM [OPG study]3.8222918
GSM537343patient 117, cancer, LCM [OPG study]4.2288228
GSM537367patient 155, cancer, LCM [OPG study]3.445798
GSM537382patient 041, cancer, LCM [OPG study]3.5296511
GSM537385patient 053, cancer, LCM [OPG study]3.5473912
GSM537391patient 073, cancer, LCM [OPG study]3.385098
GSM537419patient 045, cancer, LCM [OPG study]3.478199
GSM537420patient 052, cancer, LCM [OPG study]4.0896223
GSM537429patient 089, cancer, LCM [OPG study]4.0047824
GSM537431patient 096, cancer, LCM [OPG study]4.3720629
GSM537387patient 061, cancer, LCM [OPG study]9.2711289
GSM537414patient 028, cancer, LCM [OPG study]3.5410212
GSM537433patient 098, cancer, LCM [OPG study]4.0713724
GSM537335patient 104, cancer, LCM [OPG study]3.5608412
GSM537339patient 111, cancer, LCM [OPG study]3.601314
GSM537340patient 113, cancer, LCM [OPG study]3.6194213
GSM537344patient 118, cancer, LCM [OPG study]3.7939417
GSM537346patient 011, cancer, LCM [OPG study]4.0353923
GSM537351patient 128, cancer, LCM [OPG study]3.482429
GSM537352patient 134, cancer, LCM [OPG study]3.4953811
GSM537359patient 144, cancer, LCM [OPG study]3.437978
GSM537360patient 145, cancer, LCM [OPG study]3.4880510
GSM537364patient 152, cancer, LCM [OPG study]3.8364418
GSM537365patient 153, cancer, LCM [OPG study]3.329866
GSM537372patient 024, cancer, LCM [OPG study]3.39167
GSM537384patient 048, cancer, LCM [OPG study]3.7217415
GSM537394patient 081, cancer, LCM [OPG study]4.221227
GSM537403patient 121, cancer, LCM [OPG study]3.8419318
GSM537406patient 131, cancer, LCM [OPG study]4.5357234
GSM537411patient 149, cancer, LCM [OPG study]3.5962811
GSM537412patient 019, cancer, LCM [OPG study]3.6717314
GSM537416patient 035, cancer, LCM [OPG study]3.4730910
GSM537426patient 079, cancer, LCM [OPG study]3.5067212